@psyduckcapital · Long ARWR

Psyduck Capital Management@psyduckcapital

$ARWR Not sure if people understand the significance of this technology breakthrough and the impressive data? It should be up much more on this. Just grabbed some shares at $59

ArrowheadPharma@ArrowheadPharma

Today we announced interim Phase 1/2a clinical data for ARO-MAPT. The results represent an important step in clinical validation of our TRiM platform for delivering siRNA to the central nervous system. Join today’s webinar to learn more:

0:26

Read asLong ARWR

Since the call+96#151 → #55

#55 of 176 rankedThe analyst's rank today

High · 0.99Confidence

Wed, Oct 14Tweeted

Thu, Oct 15 closeCounted from

not in the basket todayBasket

Rank per close

#151

Oct 15

—

Oct 18

#55

Oct 19